LYNX1 CAPITAL MANAGEMENT LP Holdings

LYNX1 CAPITAL MANAGEMENT LP is an investment fund managing more than 110.87M US dollars. The largest holdings include BELLUS Health, Alpine Immune Sciences and Kinnate Biopharma. In Q3 2022 the fund bought assets of total value of 5.79M US dollars and sold assets of total value of 11.34M US dollars.

$110.86M

portfolio value

-5.63%

quarter

LYNX1 CAPITAL MANAGEMENT LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2022	14884000	21801000
Q2 2022	21127000	11435000
Q3 2022	5793000	11341000

LYNX1 CAPITAL MANAGEMENT LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology BELLUS Health Inc. Portfolio share: 22.69% Portfolio value: 25.15M Avg. open price: $8.09 Current price: $10.02 P/L: +23.86% Sold -15.87% shares Q3 2022	share	22.69%	25.15M	$8.09	$10.02	+23.86%	Sold -15.87% shares Q3 2022
Biotechnology Alpine Immune Sciences, Inc. Portfolio share: 19.85% Portfolio value: 22.00M Avg. open price: $9.29 Current price: $6.78 P/L: -27.07% Bought +58.62% shares Q3 2022	share	19.85%	22.00M	$9.29	$6.78	-27.07%	Bought +58.62% shares Q3 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 18.05% Portfolio value: 20.01M Avg. open price: $11.26 Current price: $7.05 P/L: -37.39% Bought +141.83% shares Q2 2022	share	18.05%	20.01M	$11.26	$7.05	-37.39%	Bought +141.83% shares Q2 2022
Biotechnology Merus N.V. Portfolio share: 11.08% Portfolio value: 12.28M Avg. open price: $29.4 Current price: $14.2 P/L: -51.70% Sold -38.77% shares Q3 2022	share	11.08%	12.28M	$29.4	$14.2	-51.70%	Sold -38.77% shares Q3 2022
Biotechnology CymaBay Therapeutics, Inc. Portfolio share: 7.34% Portfolio value: 8.14M Avg. open price: $3.13 Current price: $4.17 P/L: +33.11% Sold -10.19% shares Q3 2022	share	7.34%	8.14M	$3.13	$4.17	+33.11%	Sold -10.19% shares Q3 2022
Biotechnology Aerovate Therapeutics, Inc. Portfolio share: 4.13% Portfolio value: 4.58M Avg. open price: $17.24 Current price: $18 P/L: +4.43% Bought +44.31% shares Q3 2022	share	4.13%	4.58M	$17.24	$18	+4.43%	Bought +44.31% shares Q3 2022
Biotechnology Pardes Biosciences, Inc. Portfolio share: 3.80% Portfolio value: 4.21M Avg. open price: $13.5 Current price: $1.1 P/L: -91.85% Bought +4.36% shares Q3 2022	share	3.80%	4.21M	$13.5	$1.1	-91.85%	Bought +4.36% shares Q3 2022
Biotechnology Pieris Pharmaceuticals, Inc. Portfolio share: 3.65% Portfolio value: 4.04M Avg. open price: $3.14 Current price: $0.99 P/L: -68.51% Bought +9.05% shares Q3 2022	share	3.65%	4.04M	$3.14	$0.99	-68.51%	Bought +9.05% shares Q3 2022
Biotechnology Passage Bio, Inc. Portfolio share: 3.10% Portfolio value: 3.44M Avg. open price: $2.45 Current price: $1.16 P/L: -52.62% Bought +553.15% shares Q3 2022	share	3.10%	3.44M	$2.45	$1.16	-52.62%	Bought +553.15% shares Q3 2022
Biotechnology Immunic, Inc. Portfolio share: 3.06% Portfolio value: 3.38M Avg. open price: N/A Current price: $1.34 P/L: N/A Sold -2.89% shares Q3 2022	share	3.06%	3.38M	N/A	$1.34	N/A	Sold -2.89% shares Q3 2022
Biotechnology Theseus Pharmaceuticals, Inc. Portfolio share: 2.64% Portfolio value: 2.92M Avg. open price: $11.53 Current price: $6.03 P/L: -47.70% Bought +41.49% shares Q2 2022	share	2.64%	2.92M	$11.53	$6.03	-47.70%	Bought +41.49% shares Q2 2022
Biotechnology Otonomy, Inc. Portfolio share: 0.62% Portfolio value: 682K Avg. open price: $2.08 Current price: $0.13 P/L: -93.70% Bought +7609.60% shares Q3 2022	share	0.62%	682K	$2.08	$0.13	-93.70%	Bought +7609.60% shares Q3 2022

Showing TOP 12 LYNX1 CAPITAL MANAGEMENT LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of LYNX1 CAPITAL MANAGEMENT LP?

The biggest position of the LYNX1 CAPITAL MANAGEMENT LP is BELLUS Health Inc. (BLU) with 22.69% portfolio share worth of 25.16M US dollars.

Top 5 LYNX1 CAPITAL MANAGEMENT LP's holdings represent 79.01% of the portfolio:

BELLUS Health Inc. (BLU) – 22.69%
Alpine Immune Sciences, Inc. (ALPN) – 19.85%
Kinnate Biopharma Inc. (KNTE) – 18.05%
Merus N.V. (MRUS) – 11.08%
CymaBay Therapeutics, Inc. (CBAY) – 7.34%

Who is the portfolio manager of LYNX1 CAPITAL MANAGEMENT LP?

The portfolio manager of the LYNX1 CAPITAL MANAGEMENT LP is .

What is the total asset value of the LYNX1 CAPITAL MANAGEMENT LP portfolio?

LYNX1 CAPITAL MANAGEMENT LP total asset value (portfolio value) is 110.87M US dollars.

Who is ?

is the portfolio manager of the LYNX1 CAPITAL MANAGEMENT LP.

What is (LYNX1 CAPITAL MANAGEMENT LP) fund performance?

LYNX1 CAPITAL MANAGEMENT LP's quarterly performance is -5.63%, annualy 0.00%.

What is the LYNX1 CAPITAL MANAGEMENT LP CIK?

LYNX1 CAPITAL MANAGEMENT LP's Central Index Key is 0001910456 .